Invaio Sciences, Inc. recently announced an agreement with Brazil’s Fundecitrus to evaluate the use of a natural peptide to control HLB in Brazil.
The agreement will leverage Fundecitrus’ expertise in citrus grove and pest management to evaluate application details of the novel peptide maSAMP in locally relevant conditions. The peptide was developed by Hailing Jin of the University of California Riverside. It is licensed for global commercialization by Invaio, and has previously been proven under greenhouse conditions to reduce the multiplication of the pathogen that causes HLB.
Fundecitrus is a non-profit private Brazilian citrus industry association that works for the interests of the citrus growers and industry. Fundecitrus has been leading efforts to ensure that Brazilian citrus growers have access to the latest technologies, techniques and information enabling the sustainable production of citrus products.
“The collaboration will focus on the application of Invaio’s pioneering technologies to evaluate efficacy and assess measurable improvements to tree health,” said Invaio Sciences President and Chief Commercial Officer Peleg Chevion.
Invaio is already testing the technology in field trials in Florida. The goal of the Fundecitrus collaboration is to bring the benefit of the technology to Brazil and other citrus-growing regions.
“We are very pleased to work with some of the world’s experts in HLB management in Brazil, to best understand how to apply this sustainable and innovative technology and improve the economic conditions of citrus growers,” said Avram Slovic, Invaio’s senior commercial director of Latin America. “While we understand these studies are preliminary, we are confident that together with Fundecitrus we have the right team in place in order to integrate our technologies with current practices.”
HLB, spread by the Asian citrus psyllid, has caused severe problems for citrus growers in Brazil, Florida and most other citrus-producing regions worldwide.
Source: Invaio Sciences
Share this Post